Skip to main content

Table 2 Comparison of basic indicators of WKY and SHR groups

From: Nebivolol combined with tetrahydrobiopterin affects diastolic function in spontaneously hypertensive rats via the nitric oxide/cyclic guanosine monophosphate signalling pathway

Indexs

WKY(n = 6)

SHR(n = 6)

P

Body weight, g

251.06±12.70

246.78±5.32

0.78

Noninvasive measure

 Systolic blood pressure, mm Hg

121.10±6.56

207.66±14.12

0.001

 Heart rate, bpm

370.66±20.04

409.66±47.19

0.030

Diastolic measures

 Peak early diastolic LV filling velocity

708.2±6.52

702±11.39

0.318

 Peak E and A velocity ratio

2.03±0.12

1.55±0.08

0.014

 E/E’

20.25±0.62

22.67±0.92

0.001

 E’/ A’

1.58±0.23

0.86±0.02

<0.001

Systolic measures

 Fraction shortening, %

40.65±0.24

41.65±0.93

NS

 Ejection fraction, %

74.63±0.38

75.86±1.03

NS

LV dimensions

 LV posterior wall thickness, mm

1.26±0.08

1.37±0.02

0.014

 LV end-diastolic dimension, mm

6.03±0.03

6.04±0.05

NS

Invasive measure

 Heart rate

342.67±47.11

382.56± 46.05

0.025

Systolic function

 Max LV systolic pressure

101.55 ±4.64

146.60±11.29

0.001

 dP/dtmax, mm Hg/s

6344.01±1744.84

7975.70±1434.87

0.09

Diastolic function

 LV end-diastolic pressure

11.92± 5.94

51.64±14.96

0.001

 dP/dtmin,mm Hg/s

-4258.06±375.55

-6299.40±1192.38

0.001

 dP/dtmin/LVSP

-49.17±6.60

-38.19±5.62

0.004

 Time constant of isovolumic LV relaxation

18.51±3.35

25.9±3.38

0.001

  1. Notes: Values are mean ± SD. NS means the difference was not statistically significant. A: Peak late diastolic LV filling velocity; E: Peak early diastolic LV filling velocity; E’and A’: Maximal velocity of mitral annulus during early and late diastole, LV: Left ventricle; LVSP: LV systolic pressure; SHRs: Spontaneously hypertensive rats, WKY: Wistar-Kyoto rats